PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pharmidex Pharmaceutical Services Ltd., London, United Kingdom.\', \'Nanotechnology and Regenerative Medicine Commercialization Centre (NanoRegMed Ltd), London BioScience Innovation Centre, London, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2174/1381612826666201023143956
?:hasPublicationType
?:journal
  • Current pharmaceutical design
is ?:pmid of
?:pmid
?:pmid
  • 33100195
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.883
?:rankingScore_hIndex
  • 136
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 Vaccines in Clinical Trials and their Mode of Action for Immunity against the Virus.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33100195>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33100195>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all